Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next

Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next

Endocrinologist Jennifer Green discusses how GLP-1 drugs, like Ozempic, evolved from diabetes tools to potential treatments for addiction and heart disease, in this final installment of the obesity series. The discussion also touches on critical questions about long-term use, access, and emerging innovations. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-5-connecting-dots-broader-applications-glp-1s-and-where-were-headed-next

Avsnitt(47)

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
allt-du-velat-veta
svd-nyhetsartiklar
kapitalet-en-podd-om-ekonomi
rss-vetenskapsradion
det-morka-psyket
rss-spraket
rss-vetenskapsradion-2
medicinvetarna
rss-ufo-bortom-rimligt-tvivel-2
barnpsykologerna
dumforklarat
sexet
hacka-livet
paranormalt-med-caroline-giertz
vetenskapsradion
doden-hjarnan-kemisten
halsorevolutionen
vetenskap-och-halsa